Articles tagged with Chronic Obstructive Pulmonary Disease
A phone-based teach-to-goal program improved correct inhaler use in Medicare Advantage beneficiaries with COPD. The study found that nearly 40% of participants used their inhaler incorrectly initially, but after the program, only about 7% were incorrect, resulting in a significant reduction.
A recent study found that people with higher isoflavone consumption experienced fewer breathing-related symptoms and improved lung health. Isoflavones, commonly found in legumes and soy-based foods, may play a key role in reducing COPD symptoms.
A new study by UC San Francisco reveals that aging lung tissue can lead to catastrophic immune dysregulation, causing elderly individuals to become severely ill. The research suggests that targeting the damaged spiral of inflammaging could provide a promising therapeutic target for treating age-related respiratory diseases.
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) and the Global Lung Function Initiative (GLI) have agreed on diagnostic criteria for COPD, aiming to improve diagnosis and treatment. The new guidelines will help reduce the number of undiagnosed cases and promote the use of spirometry tests.
Researchers found that patients with both COPD and sleep apnea had significantly lower muscle strength and functional capacity compared to those with isolated COPD. The study highlights the importance of monitoring sleep-disordered breathing in the COPD population to improve quality of life.
New studies reveal that medication nonadherence in people with chronic obstructive pulmonary disease (COPD) is often caused by affordability and limited understanding of medications. This can lead to quicker lung function decline, more frequent exacerbations, and a higher symptom burden.
Researchers found that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly better patient outcomes. The dry powder inhaler was associated with a 14% lower risk of moderate or severe COPD exacerbations compared to metered-dose inhalers.
A new study reveals that neighborhood characteristics, including poverty and lower educational attainment, are associated with higher COPD-related emergency department visits and hospitalizations. Community-level interventions targeting these risk factors can help improve quality of life and reduce acute care use.
New research suggests that inhaled microplastics can cause inflammation and damage to the lungs, potentially increasing the risk of respiratory diseases such as asthma and COPD. Microplastics can also trigger inflammatory responses and deliver toxins directly into the lungs, highlighting a growing concern for lung health.
The American College of Chest Physicians (CHEST) received the 2025 Glenview Environmental Sustainability Award for Innovation, recognizing its commitment to clean energy and reduced emissions. The organization's solar panel installation at its headquarters powers medical simulation facilities using renewable energy.
A recent study by King's College London found that diagnosis rates for depression, asthma, and osteoporosis remained lower than expected after the COVID-19 pandemic. The study analyzed data from over 29 million people in England and found that diagnosis rates recovered differently across ethnic and socioeconomic groups.
The American College of Chest Physicians released a new clinical guideline on biologic management in severe asthma. The guideline provides evidence-based recommendations for selecting biologics for different patient populations, considering factors such as baseline oral corticosteroid use and comorbid conditions.
Researchers at Mount Sinai have developed an AI-powered ECG analysis tool that shows promise in detecting Chronic Obstructive Pulmonary Disease (COPD) early. The model achieved high accuracy rates across diverse populations, including a subgroup with irregular heartbeat and smoking exposure.
The UN has pledged to improve access to diagnosis and treatment for chronic obstructive pulmonary disease (COPD), which affects 480 million people worldwide. Inhaled medicines can reduce health and economic costs associated with COPD, but only 7% of pharmacies in low- and middle-income countries currently offer them.
A monthly injection has helped 90% of severe asthma patients reduce their reliance on daily steroid tablets. Treatment with tezepelumab improved asthma symptoms, lung function, and overall quality of life, with two-thirds of patients experiencing no asthma attacks.
The new system can reveal early cancers, lung disease, hidden material defects and changes in porosity without multiple exposures or complex mechanical movement. This method produces low-dose and faster images, lowering patients' radiation dose and making clinical translation feasible.
A European consortium developed a new decision-making framework to predict COPD exacerbation severity and prognostic risk, integrating three key factors: baseline health status, event intensity, and triggers. This framework, known as BAt model, aims to guide treatment strategies and improve consistency across clinical settings.
A cross-sectional survey of 29,268 participants found a significant association between dysfunctional breathing and respiratory conditions, as well as non-respiratory diseases like epilepsy. Tobacco use was also linked to increased prevalence of DB, particularly among those with comorbidities.
World COPD Day on November 19 highlights the significance of correctly diagnosing chronic obstructive pulmonary disease (COPD) earlier. Up to 70% of adults with COPD remain undiagnosed, leading to poorer quality of life and health outcomes. Active case finding through spirometry can improve diagnosis and treatment.
A cross-sectional study investigated the relationship between systemic immune-inflammation index (SII) and in-hospital mortality in ICU patients with chronic obstructive pulmonary disease (COPD) and atrial fibrillation (AF). The results showed a nonlinear association between SII and in-hospital mortality, with higher SII values associa...
A CT-based whole-lung radiomic nomogram accurately identifies AECOPD, offering a robust tool for clinical diagnosis and treatment planning. The nomogram demonstrated near-equivalent diagnostic performance to the radiomic score model, surpassing that of the clinical model.
The study demonstrated that nebulized HL231 at 261 µg/141 µg dose achieved comparable bronchodilation efficacy, pharmacokinetic profiles, and safety outcomes to Ultibro. HL231 showed a clear dose-response relationship with predominantly mild-to-moderate adverse events.
This study evaluates the effectiveness of staged versus simultaneous bilateral lung volume reduction surgery in patients with severe emphysema. Both approaches significantly improve pulmonary function tests, but the staged approach offers a better composite outcome of overall survival and transplant-free survival.
A new Northwestern University study reveals that abnormal cells in transplanted lungs engage in harmful 'conversations' with the immune system, leading to damage and rejection. The findings provide a comprehensive roadmap for treating chronic lung allograft dysfunction and other scarring lung diseases.
The analysis of 2024 English voting patterns suggests that poorer health is associated with higher proportions of votes for Reform UK. This finding highlights the need for policymakers to address health inequalities and improve public health.
The American College of Chest Physicians has designated October 19, 2025, as 'Love Your Lungs Day' in recognition of respiratory health. This initiative aims to raise awareness about lung diseases such as asthma and COPD, promoting equity and supporting healthcare providers.
Researchers aim to determine if biomarkers can identify adults at risk of developing interstitial lung disease (ILD), a chronic condition that causes inflammation and scarring in the lung tissue. The approach could lead to the development of new, better treatments with more tolerable side effects.
A pilot study found that hypnosis significantly improved patients' tolerance of masks, allowing them to breathe more comfortably. The study showed a substantial improvement in non-invasive ventilation (NIV) tolerance, reduced agitation, and lower requirements for sedation and anti-anxiety medication.
A gold-standard randomised-controlled trial found that specialised singing programmes can improve the symptoms and quality of life of people with lung disease, particularly those with chronic breathlessness. The SINFONIA study showed a significant improvement in quality of life for patients with COPD and ILD.
A new study found that inhaling marijuana daily is associated with a 44% increased chance of developing asthma. Experts say people should avoid inhaling cannabis to reduce the risk of chronic lung disease. The study's authors emphasize the need for clearer messages about the risks of cannabis use.
A new study shows that implementing a COPD care pathway can lead to shorter hospital stays, more referrals to pulmonary rehabilitation, and improved standardization of care. The study found that patients treated with the pathway had better outcomes, including being discharged home rather than to a facility.
People with schizophrenia are more likely to develop chronic obstructive pulmonary disease (COPD) due to shared genetic, socioeconomic, and environmental factors. The lack of adequate medical care also contributes to the under-diagnosis of COPD in this population.
A study found that patients who communicate with their providers have better disease management, reducing exacerbations and hospital visits. The study suggests increasing conversations about disease education and self-management strategies can improve quality of life.
A new study published in Aging-US found that frailty is associated with increased respiratory exacerbations and mortality in individuals with a history of cigarette smoking. Frail participants had a three- to five-fold higher chance of developing serious or frequent respiratory attacks, even if they had normal lung function.
A new study will investigate whether low levels of the lung protein CC16 in childhood can predict who will develop early chronic obstructive pulmonary disease (COPD) later in life. The five-year study aims to identify children at risk for early COPD and potentially intervene to prevent lung disease.
The BREATHE-3 clinical trial evaluates a novel bronchoscopic device to open airways and release trapped air in patients with severe emphysema. The study will assess the safety and efficacy of the Apreo BREATHE Airway Scaffold, an implantable device granted FDA Breakthrough Device Designation.
A new diagnostic schema for COPD improves patient identification by incorporating CT lung imaging and respiratory symptoms. This approach identified additional individuals at risk of poor respiratory outcomes and excluded those with airflow obstruction without respiratory symptoms.
The project aims to develop novel, interpretable biomarkers using advanced artificial intelligence to overcome limitations in current diagnostic tools. The team will integrate multi-modal data and biomechanics for better diagnosis and tracking of chronic obstructive pulmonary disease (COPD).
Researchers found that certain antiviral genes become less active with age in people with lupus, leading to fewer inflammatory proteins. This reversal of 'inflammaging' may explain why symptoms improve in some older patients, allowing them to approach healthy aging.
Scientists successfully generated lung cells similar to alveolar epithelial type 2 (AT2) cells from mouse embryonic fibroblasts without using stem cell technology. The AT2-like cells were generated in just 7 to 10 days, a significant reduction compared to conventional methods.
The American College of Chest Physicians launches a new initiative to aid in reducing time to diagnosis for complex lung conditions like NTM disease and bronchiectasis. The Bridging Specialties program aims to provide clinicians with essential tools for earlier detection, accurate diagnosis, and effective management.
A new study found significant variation in COPD prevalence and burden across states and insurance types, with West Virginia topping the list at 143 cases per 1,000 insured individuals and Utah ranking last at 44. The study also revealed high mortality rates among people with COPD in several states.
Researchers found that COPD patients have a larger accumulation of carbon deposits in their alveolar macrophage cells, which grow abnormally large and cause inflammation. This buildup is associated with worsened lung function.
A study characterizes how people with COPD walk, revealing that gait quality deteriorates as the disease progresses. Individuals with more severe breathing difficulties exhibit slower walking speeds, shorter steps, and lower step frequencies compared to those with milder forms of the disease.
This study investigates the immunomodulatory effects of Ejiao on chronic obstructive pulmonary disease (COPD), focusing on its impact on inflammatory pathways and macrophages. Ejiao significantly improves lung function in COPD model mice, reduces inflammation, and modulates the ER/AKT/NF-κB pathway.
Researchers will present AI models that predict chronic respiratory failure and detect airway obstruction, with key findings on asthma susceptibility, small airway disease, and lung inflammation. The studies use nasal epithelial gene expression analyses and bronchoscopy to identify potential biomarkers for ICU patient outcomes.
A new COPD diagnostic approach integrates respiratory symptoms, quality of life, spirometry, and CT imaging to accurately classify individuals with the disease. This framework reveals increased risks for mortality, exacerbations, and lung function decline among those classified as having COPD.
Researchers at Mass General Brigham discovered that patients with persistent mucus plugs in their lungs experience a faster decline in lung function compared to those without the plugs. The study suggests that therapies targeting these plugs may help slow disease progression and improve patient outcomes.
Key findings reveal oxidative stress as a prominent area in COPD studies, with hot topics including air pollution, cigarette smoke extract, and mitochondrial dysfunction. The study highlights the need for targeted antioxidants to effectively treat COPD.
Activating Nrf2 reduces senescent bronchial epithelial cells, improving lung function and decreasing inflammation in COPD models. This novel therapeutic approach targets cellular senescence and inflammation to mitigate COPD progression.
Research reveals individuals taking oral steroids for over 3 months are 6 times more likely to be diagnosed with adrenal insufficiency than those treated with non-steroidal anti-inflammatory drugs. Long-term users of inhaled steroids also face increased risk without hospitalisations.
Even among non-smokers, women are 50% more likely to develop COPD than men. The study suggests that factors other than cigarette smoke may be at play, highlighting the need for targeted prevention and treatment efforts.
A new report published in the COPD Foundation's journal found virtual pulmonary rehabilitation to be a safe and effective alternative for people with COPD who require supplemental oxygen. The program improved clinical outcomes and quality of life for participants, demonstrating its potential to increase access to care.
Researchers developed a novel rat model that closely replicates human COPD-associated cor pulmonale, exhibiting chronic lung inflammation, pulmonary hypertension, and right ventricular hypertrophy. The model provides insights into the underlying mechanisms of disease progression and potential therapeutic targets.
A new study found that increased perceived stress can lead to worsened respiratory symptoms and decreased quality of life in individuals with chronic obstructive pulmonary disease (COPD). The study also examined the association between stress and platelet activation, oxidative stress, and systemic inflammation.
Aspiro Therapeutics is advancing an innovative inhaled therapy for asthma and COPD using peptidomimetics based on CC16. The treatment aims to address the underlying mechanism driving respiratory conditions, providing a more effective option for patients.
A new study found that a hybrid music therapy intervention improved mental health in patients with heart failure and COPD. The pilot study also identified solutions to improve future research, including strategies for post-discharge engagement.
A recent study of 249,190 individuals found a significant link between exclusive e-cigarette use and chronic obstructive pulmonary disease (COPD) and hypertension in adults aged 30-70. In contrast, traditional combustible cigarette smoking was associated with increased risks for various cardiometabolic diseases.
A major Danish nationwide cohort study found that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) experience significantly worse health outcomes, including a 2.7-fold higher risk of death within one year compared to the general population. RSV-ARI also leads to exacerbations of COPD and asthma, ...
The American College of Chest Physicians' CHEST Critical Care and CHEST Pulmonary journals have been indexed in Elsevier's Scopus database. This achievement is a testament to the high-quality research published in these journals, which provide open access content in pulmonary and critical care medicine.